Correlation Between Centessa Pharmaceuticals and Virax Biolabs

Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and Virax Biolabs Group, you can compare the effects of market volatilities on Centessa Pharmaceuticals and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and Virax Biolabs.

Diversification Opportunities for Centessa Pharmaceuticals and Virax Biolabs

-0.2

Correlation Coefficient

Centessa Pharmaceuticals  Virax Biolabs

Good diversification

The 3 months correlation between Centessa and Virax is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and Virax Biolabs go up and down completely randomly.

Pair Corralation between Centessa Pharmaceuticals and Virax Biolabs

Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to under-perform the Virax Biolabs. But the stock apears to be less risky and, when comparing its historical volatility, Centessa Pharmaceuticals PLC is 2.59 times less risky than Virax Biolabs. The stock trades about -0.02 of its potential returns per unit of risk. The Virax Biolabs Group is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  195.00  in Virax Biolabs Group on December 1, 2024 and sell it today you would lose (28.00) from holding Virax Biolabs Group or give up 14.36% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Centessa Pharmaceuticals PLC  vs.  Virax Biolabs Group

Centessa Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Centessa Pharmaceuticals PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Centessa Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Virax Biolabs Group

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Virax Biolabs Group are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Virax Biolabs may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Centessa Pharmaceuticals and Virax Biolabs

The main advantage of trading using opposite Centessa Pharmaceuticals and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.

The idea behind Centessa Pharmaceuticals PLC and Virax Biolabs Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.